Cwm, LLC Dexcom Inc Transaction History

Cwm, LLC

$20.6 Billion
Q1 2024

A detailed history of Cwm, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cwm, LLC holds 145,866 shares of DXCM stock, worth $16.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

145,866

Previous 148,169 1.55%

Holding current value

$16.2 Million

Previous $18.4 Million 10.04%

% of portfolio

0.1%

Previous 0.1%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$114.22 - $140.1 $263,048 - $322,650	-2,303 Reduced 1.55%	145,866 $20.2 Million
Q4 2023 Feb 01, 2024	BUY	$75.49 - $124.16 $149,168 - $245,340	1,976 Added 1.35%	148,169 $18.4 Million
Q3 2023 Oct 11, 2023	BUY	$86.06 - $137.93 $12.1 Million - $19.4 Million	140,633 Added 2529.37%	146,193 $13.6 Million
Q2 2023 Aug 03, 2023	BUY	$112.47 - $130.98 $61,970 - $72,169	551 Added 11.0%	5,560 $715,000
Q1 2023 Apr 28, 2023	BUY	$104.0 - $122.92 $37,752 - $44,619	363 Added 7.81%	5,009 $582,000

Q4 2022 Feb 01, 2023	BUY	$84.98 - $122.67 $53,792 - $77,650	633 Added 15.77%	4,646 $526,000
Q3 2022 Oct 27, 2022	BUY	$76.35 - $94.18 $92,536 - $114,146	1,212 Added 43.27%	4,013 $323,000
Q2 2022 Jul 28, 2022	BUY	$67.99 - $132.89 $155,697 - $304,318	2,290 Added 448.14%	2,801 $209,000
Q1 2022 Apr 21, 2022	BUY	$94.08 - $130.2 $21,262 - $29,425	226 Added 79.3%	511 $261,000
Q4 2021 Jan 31, 2022	BUY	$129.87 - $162.82 $25,324 - $31,749	195 Added 216.67%	285 $153,000
Q1 2021 Sep 15, 2021	BUY	$84.79 - $104.74 $1,526 - $1,885	18 Added 25.0%	90 $38,000
Q1 2021 Apr 27, 2021	SELL	$84.79 - $104.74 $1,526 - $1,885	-18 Reduced 20.0%	72 $26,000
Q4 2020 Sep 15, 2021	BUY	$78.0 - $104.5 $1,404 - $1,881	18 Added 25.0%	90 $38,000
Q4 2020 Jan 27, 2021	SELL	$78.0 - $104.5 $1,404 - $1,881	-18 Reduced 20.0%	72 $27,000
Q3 2020 Sep 15, 2021	SELL	$95.51 - $112.95 $12,607 - $14,909	-132 Reduced 59.46%	90 $38,000
Q3 2020 Oct 19, 2020	BUY	$95.51 - $112.95 $12,607 - $14,909	132 Added 146.67%	222 $92,000
Q2 2020 Sep 15, 2021	SELL	$62.68 - $105.34 $8,085 - $13,588	-129 Reduced 58.9%	90 $38,000
Q2 2020 Jul 22, 2020	BUY	$62.68 - $105.34 $8,085 - $13,588	129 Added 143.33%	219 $89,000
Q1 2020 Sep 15, 2021	SELL	$47.79 - $75.63 $46,260 - $73,209	-968 Reduced 91.49%	90 $38,000
Q1 2020 Apr 28, 2020	BUY	$47.79 - $75.63 $46,260 - $73,209	968 Added 1075.56%	1,058 $285,000
Q4 2019 Sep 14, 2021	SELL	$36.62 - $57.29 $3,259 - $5,098	-89 Reduced 49.72%	90 $38,000
Q4 2019 Jan 27, 2020	BUY	$36.62 - $57.29 $3,259 - $5,098	89 Added 98.89%	179 $39,000
Q3 2019 Sep 14, 2021	SELL	$35.53 - $43.8 $8,420 - $10,380	-237 Reduced 72.48%	90 $38,000
Q3 2019 Oct 22, 2019	BUY	$35.53 - $43.8 $8,420 - $10,380	237 Added 263.33%	327 $49,000
Q2 2019 Sep 14, 2021	SELL	$27.84 - $38.92 $1.42 Million - $1.99 Million	-51,054 Reduced 99.82%	90 $38,000
Q2 2019 Jul 31, 2019	BUY	$27.84 - $38.92 $1.42 Million - $1.99 Million	51,054 Added 56726.67%	51,144 $7.66 Million
Q1 2019 Sep 02, 2021	SELL	$28.07 - $38.18 $1.12 Million - $1.52 Million	-39,785 Reduced 99.77%	90 $0
Q1 2019 Apr 22, 2019	BUY	$28.07 - $38.18 $202,244 - $275,086	7,205 Added 22.05%	39,875 $4.75 Million
Q4 2018 Jan 25, 2019	BUY	$26.99 - $37.37 $180,940 - $250,528	6,704 Added 25.82%	32,670 $3.91 Million
Q3 2018 Oct 29, 2018	SELL	$23.35 - $36.72 $216,104 - $339,843	-9,255 Reduced 26.28%	25,966 $3.71 Million
Q2 2018 Jul 31, 2018	SELL	$17.54 - $25.22 $312,948 - $449,975	-17,842 Reduced 33.62%	35,221 $3.35 Million
Q1 2018 Apr 26, 2018	SELL	$13.06 - $18.54 $26,864 - $38,136	-2,057 Reduced 3.73%	53,063 $3.94 Million
Q4 2017 Jan 16, 2018	BUY	$11.12 - $15.38 $335,534 - $464,076	30,174 Added 120.96%	55,120 $3.16 Million
Q3 2017 Oct 16, 2017	BUY	$11.36 - $18.98 $283,386 - $473,475	24,946	24,946 $1.22 Million

Others Institutions Holding DXCM

# of Institutions

1,124

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $42.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account